AU2110099A - Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host - Google Patents
Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a hostInfo
- Publication number
- AU2110099A AU2110099A AU21100/99A AU2110099A AU2110099A AU 2110099 A AU2110099 A AU 2110099A AU 21100/99 A AU21100/99 A AU 21100/99A AU 2110099 A AU2110099 A AU 2110099A AU 2110099 A AU2110099 A AU 2110099A
- Authority
- AU
- Australia
- Prior art keywords
- neuropathology
- pathophysiology
- inhibit
- host
- protease inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000007171 neuropathology Effects 0.000 title 1
- 230000007310 pathophysiology Effects 0.000 title 1
- 239000003001 serine protease inhibitor Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7073698P | 1998-01-08 | 1998-01-08 | |
| US60070736 | 1998-01-08 | ||
| PCT/US1999/000465 WO1999034789A1 (en) | 1998-01-08 | 1999-01-08 | Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2110099A true AU2110099A (en) | 1999-07-26 |
Family
ID=22097073
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU21100/99A Abandoned AU2110099A (en) | 1998-01-08 | 1999-01-08 | Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP1043987A4 (en) |
| AU (1) | AU2110099A (en) |
| WO (1) | WO1999034789A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001231137A1 (en) * | 2000-01-25 | 2001-08-07 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Treatment of neuropsychiatric disease with protease and neuraminidase inhibitors |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DD81393A (en) * | ||||
| DE4303646A1 (en) * | 1993-02-09 | 1994-08-11 | Basf Ag | The use of thrombin inhibitors to combat neurodegenerative diseases |
| US5786187A (en) * | 1995-09-21 | 1998-07-28 | The Research Foundation Of State University Of New York | Method for reducing neuronal degeneration associated with seizure |
-
1999
- 1999-01-08 AU AU21100/99A patent/AU2110099A/en not_active Abandoned
- 1999-01-08 EP EP99901395A patent/EP1043987A4/en not_active Withdrawn
- 1999-01-08 WO PCT/US1999/000465 patent/WO1999034789A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP1043987A4 (en) | 2004-03-31 |
| EP1043987A1 (en) | 2000-10-18 |
| WO1999034789A1 (en) | 1999-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2790895A (en) | Purification of serine protease and synthetic inhibitors thereof | |
| AU4236796A (en) | Cysteine protease and serine protease inhibitors | |
| AU4330899A (en) | Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors | |
| AU3972697A (en) | Inhibitors of cysteine protease | |
| AU5481498A (en) | Benzamidoaldehydes and their use as cysteine protease inhibitors | |
| AU8875398A (en) | 1-amino-7-isoquinoline derivatives as serine protease inhibitors | |
| AU2001249670A1 (en) | Substituted thiazoles and the use thereof as inhibitors of plasminogen activatorinhibitor-1 | |
| AU6897094A (en) | Identification and use of protease inhibitors | |
| PL314838A1 (en) | Inhibitors of bp-iv-serine protease | |
| AU5748194A (en) | Mannitol derivatives and their use as inhibitors of aspartyl protease | |
| HUP9901187A3 (en) | Serine protease inhibitors | |
| HU9602886D0 (en) | Methods of prouducing effective recombinant serine protease inhibitors and uses of these inhibitors | |
| AU5329096A (en) | Peptidyl derivatives as inhibitors of pro-apoptotic cysteine proteinases | |
| AU1795697A (en) | Serine protease inhibitors | |
| AU7922694A (en) | Dipeptide boronic acid inhibitors of trypsin-like enzymes | |
| EP0923535A4 (en) | Inhibitors of cysteine protease | |
| AU1877597A (en) | Serine protease inhibitors | |
| AU1930900A (en) | Use of protease inhibitors to modulate cellular pathways, immunity and therapiesassociated therewith | |
| AU6536200A (en) | Proteases and protease inhibitors | |
| AU9624398A (en) | Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors | |
| EP1115390A4 (en) | Hydroxamate-containing cysteine and serine protease inhibitors | |
| AU2110099A (en) | Use of serine protease inhibitors to inhibit pathophysiology and neuropathology in a host | |
| GB2299583B (en) | Peptidyl inhibitors of serine proteases | |
| AU1039801A (en) | Compounds and their use as cysteine protease inhibitors | |
| AU2001253639A1 (en) | Sulfamide and bis-sulfamide amino acid derivatives as inhibitors of proteolytic enzymes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |